Pneumococcal disease is an infection caused by bacteria called Streptococcus pneumoniae, or pneumococcus.... Jul 17
Merck announced the U.S. FDA accepted for priority review a Biologics License Application for V114, Merck’s investigational 15-valent pneumococcal conjugate vaccine, for ... Jan 12
The FDA’s acceptance of our application for 20vPnC is yet another significant milestone in Pfizer’s continuing efforts to help protect adults against pneumococcal ... Dec 09
... Nov 23
Pneumococcal disease in adults is on the rise globally, in part driven by disease-causing serotypes not targeted by the currently available pneumococcal conjugate vaccine... Oct 21
-Advertisements-
.jpeg)
Monday, November 25, 2024
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)